Matches in Nanopublications for { ?s ?p "[ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP604313.RAqESMy22VmzNCkVBCVRDUqlsv6f_K8P84wHdLxfKfMQI130_assertion description "[ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP604313.RAqESMy22VmzNCkVBCVRDUqlsv6f_K8P84wHdLxfKfMQI130_provenance.
- NP617309.RA3MdoDBk7o3_THYlB-E197F9tPh68lcSCxbctZBSsJe0130_assertion description "[ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617309.RA3MdoDBk7o3_THYlB-E197F9tPh68lcSCxbctZBSsJe0130_provenance.
- NP762421.RA3qFzoVxE8IrJ8Nw_QX2aW36h2O9CmFBPlVElPlXxJd4130_assertion description "[ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP762421.RA3qFzoVxE8IrJ8Nw_QX2aW36h2O9CmFBPlVElPlXxJd4130_provenance.
- NP814043.RAVJNFbqj2w5fUhajklmKoXEZOwyzHP7qrUvXS7cVBbhY130_assertion description "[ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814043.RAVJNFbqj2w5fUhajklmKoXEZOwyzHP7qrUvXS7cVBbhY130_provenance.
- assertion description "[ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1031668.RAEXLAsIadY2zW7p47n_nLlYb8uo6jNDobIpCa-xmRAyc130_assertion description "[ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1031668.RAEXLAsIadY2zW7p47n_nLlYb8uo6jNDobIpCa-xmRAyc130_provenance.
- NP1031672.RAijKOlwvDOToXAorqOMjlMZ5LAW1x_CWR7SpItFer_uQ130_assertion description "[ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1031672.RAijKOlwvDOToXAorqOMjlMZ5LAW1x_CWR7SpItFer_uQ130_provenance.